World first clinical trial supports use of Kava to treat anxiety

(Medical Xpress)—A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety.

The study, led by the University of Melbourne and published in the Journal of Clinical Psychopharmacology, revealed Kava could be an alternative treatment to pharmaceutical products for the hundreds of thousands of Australians who suffer from Generalised (GAD)

Lead researcher, Dr Jerome Sarris from Department of Psychiatry at the University of Melbourne, said GAD is a complex condition that significantly affected people's day-today lives. Existing medications have a modest clinical effect and new effective options were needed for patients with anxiety.

"Based on previous work we have recognised that plant based medicines may be a viable treatment for patients with . In this study we've been able to show that Kava offers a potential natural alternative for the treatment of chronic clinical anxiety. Unlike some other options it has less risk of dependency and less potential for side effects," he said.

The study also found that people's (polymorphisms) of certain called GABA transporters, may modify their response to Kava.

"If this finding is replicated, it may pave the way for simple genetic tests to determine which people may be likely to have a beneficial anxiety-reducing effect from taking Kava," Dr Sarris said.

During the eight-week study, 75 patients with clinically diagnosed Generalised Anxiety Disorder were given Kava or placebo, and were regularly assessed.

Results showed a significant reduction in anxiety for the Kava group compared to the placebo group at the end of the study.

In participants diagnosed with moderate to severe GAD, Kava had an even greater effect in reducing anxiety. Following the completion of the controlled phase, 26 per cent of the Kava group were classified as in remission from their symptoms compared to six per cent of the placebo group.

Participants in the Kava group were given tablets twice per day consisting of water-soluble extracted Kava (peeled rootstock) for a total dose of 120mg of kavalactones for the first three-week controlled phase. In cases of non-response this was increased to a double-dose twice per day for the second three-week controlled phase. Participants in the placebo group took matching dummy tablets in the same manner.

Kava was also well tolerated. Results showed no significant differences across the two groups for liver function which had previously been a concern for Kava's medicinal use. In addition there were no considerable adverse reactions that could be attributed to Kava and no difference in withdrawal or addiction between the groups.

An additional novel finding of the study, recently published in Phytotherapy Research was that Kava increased women's sex drive compared to those in the , believed to be due to the reduction of anxiety, rather than any aphrodisiac effect.

Future studies confirming the genetic relationship to therapeutic response, and any libido-improving effects from Kava is now required. Dr Sarris said these significant findings are of importance to sufferers of anxiety and to the South Pacific region which relies on as a major export.

add to favorites email to friend print save as pdf

Related Stories

Research finds kava is safe and effective

May 11, 2009

(PhysOrg.com) -- UQ research has found a traditional extract of kava, a medicinal plant from the South Pacific, to be safe and effective in reducing anxiety.

The unsolved mystery of kava toxicity

Jul 13, 2011

A major new review of scientific knowledge on kava — a plant used to make dietary supplements and a trendy drink with calming effects — has left unsolved the mystery of why Pacific Island people ...

Efficacy of herbal remedies for managing insomnia

Jul 18, 2012

Approximately 1 in 3 Americans suffers from chronic sleep deprivation and another 10-15% of the population has chronic insomnia. Sleep disorders can profoundly affect a person's whole life and have been linked ...

Recommended for you

Video blinds us to the evidence, study finds

3 hours ago

Where people look when watching video evidence varies wildly and has profound consequences for bias in legal punishment decisions, a team of researchers at New York University and Yale Law School has found. ...

75 years after his death, Vienna struggles with Freud

9 hours ago

Even before Sigmund Freud fled Hitler on the Orient Express from Vienna in June 1938, the father of psychoanalysis and his ideas about sex, dreams and cocaine divided opinion in the Austrian capital.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Jeddy_Mctedder
1 / 5 (1) May 13, 2013
Yea but do you quickly build a tolerance to it?